Health & Life Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 10, 2021
Share
Health & Life Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 174.39 million compared to TWD 232.33 million a year ago. Net loss was TWD 22.16 million compared to net income of TWD 214.75 million a year ago. Basic loss per share from continuing operations was TWD 0.47 compared to basic earnings per share from continuing operations of TWD 4.53 a year ago. Diluted loss per share from continuing operations was TWD 0.47 compared to diluted earnings per share from continuing operations of TWD 4.52 a year ago. Basic loss per share was TWD 0.47 compared to basic earnings per share of TWD 4.53 a year ago. Diluted loss per share was TWD 0.47 compared to diluted earnings per share of TWD 4.52 a year ago.
For the nine months, sales was TWD 582.26 million compared to TWD 548.8 million a year ago. Net loss was TWD 29.39 million compared to net income of TWD 223.65 million a year ago. Basic loss per share from continuing operations was TWD 0.62 compared to basic earnings per share from continuing operations of TWD 4.72 a year ago. Diluted loss per share from continuing operations was TWD 0.62 compared to diluted earnings per share from continuing operations of TWD 4.71 a year ago. Basic loss per share was TWD 0.62 compared to basic earnings per share of TWD 4.72 a year ago. Diluted loss per share was TWD 0.62 compared to diluted earnings per share of TWD 4.71 a year ago.
Health&Life Co Ltd is a Taiwan-based company principally engaged in the manufacturing and sales of medical equipment. The Company mainly provides electronic blood pressure monitors, ear thermometers, blood glucose meters and drug micro-atomizers for measuring and recording the human body's systolic blood pressure, diastolic blood pressure and blood sugar. The Company sells its products in domestic and overseas markets.